300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
China
Colombia
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Argentina
Cyprus
Spain
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Bangladesh
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Rice University, VC Fund

Rice University

VC Fund

Houston, United States

Rice University is a private research university that focuses on providing undergraduate education services.The university is organized into eleven residential colleges and eight schools of academic study including the Wiess School of Natural Sciences, the George R. Brown School of Engineering, the School of Social Sciences, and the School ofHumanities. Graduate programs are offered through the Jesse H. Jones Graduate School of Business, School of Architecture, Shepherd School of Music, and Susanne M. Glasscock School of Continuing Studies. Rice University students are bound by the strict Honor Code, which a uniquely student-run Honor Council enforces.The university is noted for its applied science programs in artificial heart research, structural chemical analysis, signal processing, space science, and nanotechnology. It was ranked first in the world in materials science research by the Times Higher Education (THE) in 2010. The university is also noted for its entrepreneurial activities. It has been recognized as one of the top-ranked business incubators in the world by the Stockholm-based UBI Index for both 2013 and 2014.Rice University is a member of the Association of American Universities. Currently, it has approximately 3,900 undergraduates and 2,600 graduate students from the U.S. and 76 countries or regions. It was established in 1912 and was named after William Marsh Rice, an American businessman who bequeathed his fortune to found Rice University.

Total investments:
8
Last investment:
Lead investor:
25%

Last updated:

Industries Rice University invests in

Health CareNewsSolarVideoHunting

Stages Rice University invests in

GrantSeedSeries ASeries BDebt Financing

Countries Rice University invests in

United StatesGermany

Contacts

NameEmailPhoneSocials
Allison Thacker Allison Thacker
George McLendon George McLendon
Mary Lynn Fernau Mary Lynn Fernau
See all 17 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 2 (25%)
  • News 1 (13%)
  • Solar 1 (13%)
  • Video 1 (13%)
  • Hunting 1 (13%)
See all 30 industries →

Stage

  • Grant 3 (38%)
  • Seed 2 (25%)
  • Series A 1 (13%)
  • Series B 1 (13%)
  • Debt Financing 1 (13%)

Country

  • United States 5 (63%)
  • Germany 1 (13%)

Team

NameTitleInvestmentsLinksEmail
Allison Thacker
Allison Thacker President, Rice Management Company & Chief Investment Officer
President, Rice Management Company & Chief Investment Officer Total investments: 2
Find email
George McLendon
George McLendon Provost
Provost Total investments: 1
Find email
Mary Lynn Fernau
Mary Lynn Fernau Director, Executive and International Programs
Director, Executive and International Programs Total investments: 0
Find email
Aydin Babakhani
Aydin Babakhani Associate Professor
Associate Professor Total investments: 0
Find email
Blair Garrou
Blair Garrou Adjunct Professor of Management, Jones Graduate School of Business
Adjunct Professor of Management, Jones Graduate School of Business Total investments: 57
Find email
See all 17 team members →

Investments

CompanyDescriptionRoundLinks
Greentown Labs Greentown Labs
Greentown Labs enables entrepreneurs to solve the world's biggest energy and environmental challenges. Our mission is to enable a vibrant community of entrepreneurs to work on their visions and to provide access to the space, resources, and funding that allows their early-stage companies thrive. We offer 33,000 sq. ft. of prototyping lab andco-located office space, a shared machine shop and electronics lab, immersion in a growing community of energy and clean technology entrepreneurs, and on-site events and programs designed to enable start-ups to rapidly grow their networks and their companies. $3M / Grant / Dec 18, 2024
Greentown Labs Greentown Labs
Greentown Labs enables entrepreneurs to solve the world's biggest energy and environmental challenges. Our mission is to enable a vibrant community of entrepreneurs to work on their visions and to provide access to the space, resources, and funding that allows their early-stage companies thrive. We offer 33,000 sq. ft. of prototyping lab andco-located office space, a shared machine shop and electronics lab, immersion in a growing community of energy and clean technology entrepreneurs, and on-site events and programs designed to enable start-ups to rapidly grow their networks and their companies. $1M / Debt Financing / Dec 18, 2024
Mallard Bay Mallard Bay
Mallard Bay Outdoors is a marketplace for sportsmen who can book safe and reliable hunting and fishing spots. $200K / Grant / May 01, 2022
TransCrypts TransCrypts
TransCrypts is a tool for Human Resource Departments to automate the issuance of employment and income verification documents using the blockchain. Our proprietary process not only saves HRs time, money, and headache in dealing with compliance but also gives employees total control over how their work information is being shared. Grant / May 30, 2021
RANDIAN RANDIAN
RANDIAN is a patented platform that makes shows and videos interactive, with a full-scale e-commerce engine that drives direct sales for brands. RANDIAN’s disruptive technology is the next generation of advertising and aspirational purchasing in the digital age. $25K / Seed / Mar 30, 2019
OncoResponse OncoResponse
OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer. $40M / Series B / Sep 11, 2018
Medical Magnesium Medical Magnesium
Medical Magnesium develops metallic bioabsorbable implants for orthopedic and trauma surgery. The implants are mechanically stable and physiologically degradable after fracture healing.Our goal is to offer surgeons and patients tailor-made, highly functional magnesium-based solutions. We want to contribute to the next generation of implants,which make more and more single-surgery therapies possible. Metal removal is no longer necessary using innovative bioabsorbable implants.As a startup from RWTH Aachen University, we bring results from interdisciplinary research in engineering and medicine into surgical practice. The material technology has been developed and extensively tested as the basis for first implant products. $700K / Seed / Apr 28, 2017
OncoResponse OncoResponse
OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer. $12.5M / Series A / May 07, 2016

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
China
Colombia
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Argentina
Cyprus
Spain
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Bangladesh
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Rice University invest in?

Rice University invests primarily in Health Care, News and Solar startups, most often at Grant and Seed stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Rice University?

Public channels for Rice University include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Rice University?

The team at Rice University includes Allison Thacker (President, Rice Management Company & Chief Investment Officer), George McLendon (Provost) and Mary Lynn Fernau (Director, Executive and International Programs), among 17 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Rice University Rice University Find emails